Margriet V D Z Park

发表

Simple in vitro models can predict pulmonary toxicity of silver nanoparticles

Hedwig M Braakhuis, Willie J G M Peijnenburg, Margriet V D Z Park, 2016, Nanotoxicology.

Sensitive method for endotoxin determination in nanomedicinal product samples.

W. D. de Jong, P. Keizers, R. Vandebriel, 2019, Nanomedicine.

The value of organs-on-chip for regulatory safety assessment.

R. Vandebriel, M. Heringa, A. Kienhuis, 2019, ALTEX.

The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles.

W. D. de Jong, H. van Loveren, J. Vermeulen, 2011, Biomaterials.

Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats.

W. D. de Jong, H. van Loveren, R. Vandebriel, 2013, Biomaterials.

In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles.

Aldert H Piersma, Wim H de Jong, Margriet V D Z Park, 2009, Toxicology and applied pharmacology.

A perspective on the developmental toxicity of inhaled nanoparticles.

Aldert H Piersma, Antonio Pietroiusti, Flemming R Cassee, 2015, Reproductive toxicology.

Development of a systematic method to assess similarity between nanomaterials for human hazard evaluation purposes – lessons learnt

Margriet Vdz Park, Julia Catalán, Natalia Ferraz, 2018, Nanotoxicology.

Assessment of oxidative damage induced by iron oxide nanoparticles on different nervous system cells.

J. Teixeira, C. Costa, M. Carrière, 2019, Mutation research.

Progress and future of in vitro models to study translocation of nanoparticles

S. Kežić, H. Bouwmeester, I. Rietjens, 2015, Archives of Toxicology.

Options for imaging cellular therapeutics in vivo: a multi-stakeholder perspective.

V. Ponomarev, G. Fruhwirth, P. Blower, 2021, Cytotherapy.

Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls

W. D. de Jong, H. van Loveren, R. Vandebriel, 2020, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

A practical approach to determine dose metrics for nanomaterials

Jingwen Chen, Agnes G Oomen, Christiaan J E Delmaar, 2015, Environmental toxicology and chemistry.

Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles

H. van Loveren, F. Cassee, P. Krystek, 2014, Particle and Fibre Toxicology.

Nanomedicinal products: a survey on specific toxicity and side effects

Rob J Vandebriel, Christina Giannakou, R. Vandebriel, 2017, International journal of nanomedicine.

Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles

H. van Loveren, F. Cassee, P. Krystek, 2014, Particle and Fibre Toxicology.

Inductively Coupled Plasma‐Mass Spectrometry in Biodistribution Studies of (Engineered) Nanoparticles

P. Krystek, H. Braakhuis, Margriet V D Z Park, 2019, Encyclopedia of Analytical Chemistry.

Physicochemical characteristics of nanomaterials that affect pulmonary inflammation

Hedwig M Braakhuis, Flemming R Cassee, Ilse Gosens, 2014, Particle and Fibre Toxicology.

Quality evaluation of human and environmental toxicity studies performed with nanomaterials – the GUIDEnano approach

José María Navas, Helene Stockmann-Juvala, Claus Svendsen, 2018 .

Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay

Wim H de Jong, Margriet V D Z Park, Iseult Lynch, 2011, Nanotoxicology.

The status of in vitro toxicity studies in the risk assessment of nanomaterials.

Wim H de Jong, W. D. de Jong, H. van Loveren, 2009, Nanomedicine.

Identification of the appropriate dose metric for pulmonary inflammation of silver nanoparticles in an inhalation toxicity study

W. D. de Jong, H. van Loveren, F. Cassee, 2015, Nanotoxicology.

Interactions with the Human Body

Wim H. De Jong, Peter Wick, Margriet V. D. Z. Park, 2012 .

In vitro evaluation of cytotoxic and inflammatory properties of silica nanoparticles of different sizes in murine RAW 264.7 macrophages

Kenneth A. Dawson, Wout Slob, Iseult Lynch, 2011 .

Considerations for Safe Innovation: The Case of Graphene.

Flemming R Cassee, Willie J G M Peijnenburg, Wim H de Jong, 2017, ACS nano.

Progress and future of in vitro models to study translocation of nanoparticles

S. Kežić, H. Bouwmeester, I. Rietjens, 2015, Archives of Toxicology.

A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements

Wim H de Jong, Rob J Vandebriel, Christina Giannakou, 2016, International journal of nanomedicine.

Horizon scan of nanomedicinal products.

Agnes G Oomen, Margriet V D Z Park, Rob J Vandebriel, 2015, Nanomedicine.

Bridging communities in the field of nanomedicine

Thierry Bastogne, Valérie Zuang, Patrick Boisseau, 2019, Regulatory toxicology and pharmacology : RTP.

Systematic selection of a dose metric for metal-based nanoparticles

C. Delmaar, M. Vijver, S. Harper, 2019, NanoImpact.

Immunotoxicity Testing of Nanomedicinal Products: Possible Pitfalls in Endotoxin Determination

R. Vandebriel, H. Loveren, Geertsma Re, 2017 .

Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats.

H. van Loveren, R. Vandebriel, L. V. D. van der Ven, 2013, Biomaterials.